316 related articles for article (PubMed ID: 10525494)
1. Progressive cardiac dysfunction and fibrosis in the cardiomyopathic hamster and effects of growth hormone and angiotensin-converting enzyme inhibition.
Ryoke T; Gu Y; Mao L; Hongo M; Clark RG; Peterson KL; Ross J
Circulation; 1999 Oct; 100(16):1734-43. PubMed ID: 10525494
[TBL] [Abstract][Full Text] [Related]
2. Role of endothelin in deterioration of heart failure due to cardiomyopathy in hamsters: increase in endothelin-1 production in the heart and beneficial effect of endothelin-A receptor antagonist on survival and cardiac function.
Yamauchi-Kohno R; Miyauchi T; Hoshino T; Kobayashi T; Aihara H; Sakai S; Yabana H; Goto K; Sugishita Y; Murata S
Circulation; 1999 Apr; 99(16):2171-6. PubMed ID: 10217659
[TBL] [Abstract][Full Text] [Related]
3. Effects of quinapril, a new angiotensin converting enzyme inhibitor, on left ventricular failure and survival in the cardiomyopathic hamster. Hemodynamic, morphological, and biochemical correlates.
Haleen SJ; Weishaar RE; Overhiser RW; Bousley RF; Keiser JA; Rapundalo SR; Taylor DG
Circ Res; 1991 May; 68(5):1302-12. PubMed ID: 1850330
[TBL] [Abstract][Full Text] [Related]
4. Effects of growth hormone and IGF-I on cardiac hypertrophy and gene expression in mice.
Tanaka N; Ryoke T; Hongo M; Mao L; Rockman HA; Clark RG; Ross J
Am J Physiol; 1998 Aug; 275(2):H393-9. PubMed ID: 9683425
[TBL] [Abstract][Full Text] [Related]
5. Growth hormone preserves cardiac sarcoplasmic reticulum Ca2+ release channels (ryanodine receptors) and enhances cardiac function in cardiomyopathic hamsters.
Ueyama T; Ohkusa T; Yano M; Matsuzaki M
Cardiovasc Res; 1998 Oct; 40(1):64-73. PubMed ID: 9876318
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin II blockade followed by growth hormone as adjunctive therapy after experimental myocardial infarction.
Hongo M; Sentianin EM; Tanaka N; Mao L; McKirnan MD; Clark RG; Won W; Chien KR; Ross J
J Card Fail; 1998 Sep; 4(3):213-24. PubMed ID: 9754592
[TBL] [Abstract][Full Text] [Related]
7. Early versus delayed angiotensin-converting enzyme inhibition in experimental chronic heart failure. Effects on survival, hemodynamics, and cardiovascular remodeling.
Mulder P; Devaux B; Richard V; Henry JP; Wimart MC; Thibout E; Macé B; Thuillez C
Circulation; 1997 Mar; 95(5):1314-9. PubMed ID: 9054865
[TBL] [Abstract][Full Text] [Related]
8. Growth hormone-releasing peptide can improve left ventricular dysfunction and attenuate dilation in dilated cardiomyopathic hamsters.
Iwase M; Kanazawa H; Kato Y; Nishizawa T; Somura F; Ishiki R; Nagata K; Hashimoto K; Takagi K; Izawa H; Yokota M
Cardiovasc Res; 2004 Jan; 61(1):30-8. PubMed ID: 14732199
[TBL] [Abstract][Full Text] [Related]
9. Chronic effects of early started angiotensin converting enzyme inhibition and angiotensin AT1-receptor subtype blockade in rats with myocardial infarction: role of bradykinin.
Hu K; Gaudron P; Anders HJ; Weidemann F; Turschner O; Nahrendorf M; Ertl G
Cardiovasc Res; 1998 Aug; 39(2):401-12. PubMed ID: 9798525
[TBL] [Abstract][Full Text] [Related]
10. Clinical aspects of left ventricular diastolic function assessed by Doppler echocardiography following acute myocardial infarction.
Poulsen SH
Dan Med Bull; 2001 Nov; 48(4):199-210. PubMed ID: 11767125
[TBL] [Abstract][Full Text] [Related]
11. Serial echocardiographic-Doppler assessment of left ventricular geometry and function in rats with pressure-overload hypertrophy. Chronic angiotensin-converting enzyme inhibition attenuates the transition to heart failure.
Litwin SE; Katz SE; Weinberg EO; Lorell BH; Aurigemma GP; Douglas PS
Circulation; 1995 May; 91(10):2642-54. PubMed ID: 7743628
[TBL] [Abstract][Full Text] [Related]
12. Effects of growth hormone following chronic angiotensin-converting enzyme inhibition in chronic heart failure: their relation to infarct size.
Hongo M; Hironaka E; Yokoseki O; Watanabe N; Shibamoto T; Owa M; Ryoke T
Cardiovasc Drugs Ther; 2001; 15(3):241-9. PubMed ID: 11713892
[TBL] [Abstract][Full Text] [Related]
13. Effects of quinapril on expression of eNOS, ACE, and AT1 receptor in deoxycorticosterone acetate-salt hypertensive rats.
Hara K; Kobayashi N; Watanabe S; Tsubokou Y; Matsuoka H
Am J Hypertens; 2001 Apr; 14(4 Pt 1):321-30. PubMed ID: 11336177
[TBL] [Abstract][Full Text] [Related]
14. Myocardial expression of atrial natriuretic factor gene in early stages of hamster cardiomyopathy.
Di Nardo P; Minieri M; Carbone A; Maggiano N; Micheletti R; Peruzzi G; Tallarida G
Mol Cell Biochem; 1993 Aug; 125(2):179-92. PubMed ID: 8283973
[TBL] [Abstract][Full Text] [Related]
15. Ventricular remodeling after myocardial infarction and effects of ACE inhibition on hemodynamics and scar formation in SHR.
Zdrojewski T; Gaudron P; Whittaker P; Poelzl S; Schiemann J; Hu K; Ertl G
Cardiovasc Pathol; 2002; 11(2):88-93. PubMed ID: 11934599
[TBL] [Abstract][Full Text] [Related]
16. Dual ACE-inhibition and AT1 receptor antagonism improves ventricular lusitropy without affecting cardiac fibrosis in the congenic mRen2.Lewis rat.
Jessup JA; Westwood BM; Chappell MC; Groban L
Ther Adv Cardiovasc Dis; 2009 Aug; 3(4):245-57. PubMed ID: 19531557
[TBL] [Abstract][Full Text] [Related]
17. Chronic AT1 receptor blockade and angiotensin-converting enzyme (ACE) inhibition in (CHF 146) cardiomyopathic hamsters: effects on cardiac hypertrophy and survival.
Bastien NR; Juneau AV; Ouellette J; Lambert C
Cardiovasc Res; 1999 Jul; 43(1):77-85. PubMed ID: 10536692
[TBL] [Abstract][Full Text] [Related]
18. Effects of growth hormone on cardiac dysfunction and gene expression in genetic murine dilated cardiomyopathy.
Hongo M; Ryoke T; Schoenfeld J; Hunter J; Dalton N; Clark R; Lowe D; Chien K; Ross J
Basic Res Cardiol; 2000 Dec; 95(6):431-41. PubMed ID: 11192363
[TBL] [Abstract][Full Text] [Related]
19. The role of hypertrophy and growth factors in heart failure.
Ross J; Hongo M
J Card Fail; 1996 Dec; 2(4 Suppl):S121-8. PubMed ID: 8951569
[TBL] [Abstract][Full Text] [Related]
20. The influence of growth hormone (GH) therapy on cardiac performance in patients with childhood onset GH deficiency.
Minczykowski A; Gryczynska M; Ziemnicka K; Czepczynski R; Sowinski J; Wysocki H
Growth Horm IGF Res; 2005 Apr; 15(2):156-64. PubMed ID: 15809020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
